AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA approves enhanced labeling for liquid-based cytology.

Women's Health Weekly

| June 05, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JUN 5 - (NewsRx.com & NewsRx.net) -- TriPath Imaging, Inc., (TPTH) has received approval for expanded labeling claims from the U.S. Food and Drug Administration (FDA) to include study data showing a 64.4% (p

The enhanced labeling granted by the FDA reflects the results of a multisite "direct-to-vial" clinical trial in which the results obtained with 58,580 SurePath slides collected prospectively from 57 clinics that had converted almost 100% from conventional Pap smears were compared to an historical cohort of 58,988 conventional Pap smears.

The study was designed to reflect intended use in routine clinical and laboratory practice (a "direct to vial" study). No attempt was made to increase the yield of abnormality by isolating specific patient populations, by seeding with abnormal slides, by patient or clinic selection, or by any other mechanism. All available biopsy data were collected for both slide populations.

The results from the clinical study showed a detection rate for HSIL+ of 405/58,580 for SurePath slides as compared to 248/58,988 for conventional slides, resulting in detection rates of 0.691% and 0.420%, respectively. For these clinical sites and these study populations, this indicates a 64.4% (p

In addition, ...

Related articles from newspapers, magazines, journals, and more
Significance of margin and extent of dysplasia in loop electrosurgery excision...
Magazine article from: Archives of Pathology & Laboratory Medicine Tyler, Lisa N. Andrews, Nancy Parrish, Rudolph S. Hazlett, Linda J. Korourian, Soheila April 1, 2007 700+ words
...High-grade squamous intraepithelial lesions (cervical...persistence of high-grade squamous intraepithelial lesion and to provide...residual high-grade squamous intraepithelial lesions. This association...
Is the human papillomavirus test in combination with the papanicolaou test...
Magazine article from: Archives of Pathology & Laboratory Medicine Lee, Nak-Woo Kim, Daesu Park, Jong-Tae Kim, Aeree November 1, 2001 700+ words
...do not satisfy the criteria of squamous intraepithelial lesion (SIL). (1, 3, 4...uniformly agreed upon. Low-grade squamous intraepithelial lesion (LSIL) represents human...or underdiagnosed high-grade squamous intraepithelial lesions (HSILs) or squamous...
Association of vitamin A deficiency with cervical squamous intraepithelial...
Magazine article from: Alternative Medicine Review French AL Kirstein LM Massad LS December 1, 2000 700+ words
...Association of vitamin A deficiency with cervical squamous intraepithelial lesions in human immunodeficiency virus...vitamin A (retinol) deficiency and cervical squamous intraepithelial lesions (SILs) in human immunodeficiency...
Frequency of cervical stenosis and persistent disease following treatment of...
Magazine article from: Southern Medical Journal Sapp, Atyia Robinson, Christopher Underwood, Paul Roginsky, Rina Armstrong, C. Michael October 1, 2004 700+ words
The objective was to compare the frequency of cervical stenosis and persistence of SIL following LEEP vs cryotherapy. After IRB approval, a retrospective cohort study was conducted via chart review of patients treated for SIL at our tertiary care center from July 1999 until June 2000. Exclusion
FDA Approves Enhanced Labeling for TriPath Imaging's Liquid Based Cytology;...
Press release article from: PR Newswire May 5, 2003 700+ words
...High Grade Squamous Intraepithelial and more...58,580 SurePath slides collected...lesions for the SurePath slides. In addition...Low Grade Squamous Intraepithelial and more...LSIL+) for SurePath slides of 3.371...
FDA approves enhanced labelling for TriPath Imaging's liquid based cytology.
Press release article from: PR Newswire May 5, 2003 700+ words
...High Grade Squamous Intraepithelial and more...58,580 SurePath slides collected...lesions for the SurePath slides. In addition...Low Grade Squamous Intraepithelial and more...LSIL+) for SurePath slides of 3.371...
New cytology study findings recently were reported by researchers at...
Newspaper article from: Clinical Trials Week November 30, 2009 700+ words
...FocalPoint GS Imaging System using SurePath slides (BD Diagnostics-TriPath...ASC-US+), low-grade squamous intraepithelial lesion and greater (LSIL+), and high-grade squamous intraepithelial lesion and greater (HSIL...
Findings in cytology reported from F. Alameda and co-researchers.
Newspaper article from: Cancer Weekly November 3, 2009 700+ words
...cytologic diagnosis for low-grade squamous intraepithelial lesions, using liquid-based...negative cytologic diagnosis for squamous intraepithelial lesion or malignancy (20 premenopausal...negative cases) and 30 low-grade squamous intraepithelial lesion cases. The follow-up...
For more facts and information, see all results

Source: HighBeam Research, FDA approves enhanced labeling for liquid-based cytology.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA